News & Publications Share Print Industry News Biotech Startups Use Models of Human Organs for Drug Discovery The Wall Street Journal April 26, 2023 Read More Featured Story This Startup Just Raised $70 Million To Grow Tiny Tumors That Create Personalized Cancer Treatments Forbes November 17, 2021 Read More Xilis in the News Xilis Announces Formation of its Scientific Advisory Board PR Newswire December 15, 2022 Read More Xilis Aims to Demonstrate Ability of Drug Screening Micro-Tumors to Personalize Cancer Therapy Precision Oncology May 25, 2022 Read More Check out these startups from Pear’s Demo Day (there’s usually a breakout or two in the bunch) TechCrunch October 15, 2021 Read More load more Press Releases Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development PR Newswire February 15, 2023 Read More Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million Business Wire July 13, 2022 Read More Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory Board Business Wire June 8, 2022 Read More Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs Business Wire May 3, 2022 Read More Xilis Presents Data at ESMO 2021 Demonstrating Capabilities of MicroOrganoSphere™ Technology for Cancer Drug Screening Business Wire September 20, 2021 Read More Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and … Business Wire July 8, 2021 Read More Publications A path to translation: How 3D patient tumor avatars enable next generation precision oncology ScienceDirect October 20, 2022 Read More Rapid tissue prototyping with micro-organospheres Cell Stem Cell September 13, 2022 Read More Patient-derived micro-organospheres enable clinical precision oncology Cell Stem Cell June 2, 2022 Read More Posters Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer (MODEL-ABC) ASCO 2023 June 14, 2023 Read More MicroOrganoSpheres as a Clinically Applicable Precision Oncology Platform for the Discovery of Novel Therapies in Colorectal Cancer ASCO 2023 June 9, 2023 Read More Patient-derived MicroOrganoSpheres (MOS)TM and clinical response to immunotherapy ASCO 2023 June 9, 2023 Read More load more Abstracts Refractory colorectal cancer patient-derived MicroOrganoSpheres (MOS)TM enables correlation of targeted therapy combination response with clinical outcomes ASCO 2023 June 10, 2023 Read More A functional immuno-oncology (IO) assay to assess patient response to immunotherapeutics in metastatic disease ASCO 2023 June 10, 2023 Read More Establishing functional models of peritoneal carcinomatosis using MicroOrganoSphere (MOS) technology ASCO 2023 June 10, 2023 Read More
